$11.0M
The round was led by We Venture Capital and Cross-Border Impact Ventures to support the development of liquid biopsy tests.
O
OXcan
Oxford Cancer Analytics develops blood tests for early cancer detection.
Oxford, UK—Founded 2020
$11.0MTotal raised
Oxford Cancer Analytics develops protein based blood tests for the early detection of lung cancer using advanced proteomics and artificial intelligence.
Categories
Team
Andreas Halner
Co-founder
Andreas brings healthcare and analytical experience from founding Oxford Cancer Analytics and working with the CICERO Clinical Research Collaboration. He also taught pathology at St John's College, Oxford.
BW
Brad Wilson
Chairman